×

img Acces sibility Controls

Research Projects Banner

Research Projects

Mechanism of beta adrenoreceptor signaling regulation in mesenchymal stromal cells during aging

Implementing Organization

Mahindra University
Principal Investigator
Dr. Pijus Kanti Barman
Mahindra University

Project Overview

Beta-adrenoreceptors (?-ARs) are G protein-coupled receptors that mediate physiological responses to neurotransmitters. ?2- and ?3-AR signaling defects lead to various diseases, including aging, cardiovascular disorders, and cancer. Increased and decreased ?2- and ?3-AR signaling in bone marrow mesenchymal stromal cells (MSCs) cause hematopoietic stem cell (HSC) dysfunction in aging, with ?2- and ?3-AR signaling playing opposite roles in HSC migration. Osteopontin (OPN), produced by osteoblasts, MSCs, endothelial, and other cells, has multiple functions including ?2-AR signaling regulation. Reduced OPN due to osteoblast loss causes HSC dysfunction in aged mouse bone marrow. However, it is unclear whether there is a link between reduced OPN and imbalanced ?2- and ?3-AR signaling in bone marrow MSCs during aging. The current study aims to fill this gap in literature by hypothesizing that ?2- and ?3-AR signaling regulate each other via OPN, and that aging alters the balance between ?2- and ?-3AR signaling in bone marrow MSCs by downregulating OPN. Methods include stimulation of MS-5 human stromal cells with clenbuterol and BRL37344, and ?2- and ?3-AR signaling proteins in intracellular cAMP and ?-AR signaling proteins. The study also examines agonist-induced ?2- and ?3-AR signaling in OPN knockdown MS-5 cells, bone marrow and blood plasma expression of OPN in young and old WT mice, and OPN stimulation in young and old mouse MSCs.
Funding Organization
Funding Organization
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Year
2024
End Year
2026
Sanction Amount
₹ 32.49 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop